Literature DB >> 9730856

Nitric oxide synthase activity is increased in relation to the severity of liver dysfunction.

H F Galley1, D Coomansingh, N R Webster, P W Brunt.   

Abstract

1. Nitric oxide is a potent vasodilator which plays a major role in the control of blood pressure. The hyperdynamic circulation of cirrhosis has been linked to nitric oxide.2. We measured neutrophil nitric oxide synthase activity in relation to the level of hepatic dysfunction in patients with liver disease of varying aetiology and severity.3. Neutrophils were isolated from 21 patients (7 Child-Pugh score A, 6 grade B and 8 grade C) aged 28-76 (median 49) years. Nitric oxide synthase activity was measured using the conversion of oxyhaemoglobin to methaemoglobin by nitric oxide and expressed in terms of cell protein. Blood pressure and biochemical indices were recorded. Data were assessed using Kruskal-Wallis one-way analysis of variance, Mann-Whitney U-test or Pearson correlation as appropriate.4.Systolic, mean arterial and diastolic blood pressures decreased with increasing hepatic damage (P=0.031, P=0.01 and P=0. 038 respectively). Nitric oxide synthase activity increased with the degree of liver dysfunction (P=0.033) and was highest in patients with Child-Pugh score C. Systolic blood pressure correlated with nitric oxide synthase activity in patients with Child-Pugh score C (P=0.029).5. Our results show that nitric oxide synthase activity increases with increasing Child-Pugh score and is associated with the development of systemic hypotension. These data may support the involvement of nitric oxide in the haemodynamic disturbances seen in liver disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730856

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Distribution of nitric oxide synthase in normal and cirrhotic human liver.

Authors:  Lance McNaughton; Lakshmi Puttagunta; Maria Angeles Martinez-Cuesta; Norm Kneteman; Irvin Mayers; Redwan Moqbel; Qutayba Hamid; Marek W Radomski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

2.  Changes in the level of cytosolic calcium, nitric oxide and nitric oxide synthase activity during platelet aggregation: an in vitro study in platelets from normal subjects and those with cirrhosis.

Authors:  Sam Annie-Jeyachristy; Arumugam Geetha; Rajagopal Surendran
Journal:  J Biosci       Date:  2008-03       Impact factor: 1.826

3.  Use of methylene blue for treatment of severe sepsis in an immunosuppressed patient after liver transplantation.

Authors:  Saravanan Ramamoorthy; Shachi Patel; Eric Bradburn; Zakiyah Kadry; Tadahiro Uemura; Piotr K Janicki; Riaz Ali Shah; Dmitri Bezinover
Journal:  Case Rep Transplant       Date:  2013-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.